After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Xeris Biopharma Holdings Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Xeris Biopharma Holdings Inc is $357.31M. A total of 1.06 million shares were traded on the day, compared to an average of 1.32M shares.
In the most recent transaction, Schmid John P. bought 5,400 shares of XERS for 1.91 per share on May 10 ’24. After the transaction, the Director now owns 16,400 company shares. In a previous transaction on Mar 14 ’24, Schmid John P. bought 4,500 shares at 2.16 per share. XERS shares that Director owns now total 11,000.
Among the insiders who bought shares, SHERMAN JEFFREY W acquired of 5,400 shares on Nov 27 ’23 at a per-share price of $1.87. This resulted in the Director holding 5,400 shares of XERS after the transaction. In another insider transaction, Pieper Steven bought 28,000 shares at $1.95 per share on Nov 20 ’23. Company shares held by the insider now total 1,176,912.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, XERS has a high of $3.26 and a low of $1.46.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. XERS’s latest balance sheet shows that the firm has $102.43M in Cash & Short Term Investments as of fiscal 2021. There were $88.07M in debt and $79.04M in liabilities at the time. Its Book Value Per Share was -$0.06, while its Total Shareholder’s Equity was $95.23M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XERS is Buy with a score of 5.00.
